- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2625EUR$2,750USD£2,199GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2625EUR$2,750USD£2,199GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2625EUR$2,750USD£2,199GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2625EUR$2,750USD£2,199GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2625EUR$2,750USD£2,199GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2625EUR$2,750USD£2,199GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2625EUR$2,750USD£2,199GBP
- Report
- February 2024
- 140 Pages
Global
From €4742EUR$4,969USD£3,973GBP
- Report
- April 2023
- 147 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- April 2023
- 147 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- September 2024
- 82 Pages
Japan
From €3340EUR$3,500USD£2,799GBP
- Report
- September 2024
- 82 Pages
Japan
From €3340EUR$3,500USD£2,799GBP
- Report
- August 2024
- 80 Pages
Japan
From €3340EUR$3,500USD£2,799GBP
- Report
- October 2023
- 190 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2023
- 173 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2023
- 189 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2023
- 181 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- May 2023
- 160 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- April 2023
- 147 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- October 2023
- 145 Pages
Global
From €3006EUR$3,150USD£2,519GBP

The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications.
The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more